Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer

Laryngoscope

Volumn 124, Issue 5, 2014, Pages 1134-1140

  Hsin, Li Jen ^a   Fang, Tuan Jen ^a   Tsang, Ngan Ming ^b   Chin, Shy Chyi ^b   Yen, Tzu Chen ^b   Li, Hsueh Yu ^a   Liao, Chun Ta ^a   Chen, I How ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

prognosticator; survival; T4a laryngeal cancer; tumor volume

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TRACHEOSTOMY; TUMOR INVASION; TUMOR VOLUME; VERY ELDERLY; VOLUMETRY;

PROGNOSTICATOR; SURVIVAL; T4A LARYNGEAL CANCER; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84899426074     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24461     Document Type: Article

References (20)

1. DoVALCSG,. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991; 324: 1685-1690.
2. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098.
3. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116: 1-13.
4. Chen AY, Schrag N, Hao Y, et al. Changes in treatment of advanced laryngeal cancer 1985-2001. Otolaryngol Head Neck Surg 2006; 135: 831-837.
5. Chen AY, Halpern M,. Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol 2007; 133: 1270-1276.
6. Bussu F, Micciche F, Rigante M, et al. Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases. Head Neck 2012; 34: 573-579.
7. Gourin CG, Conger BT, Sheils WC, Bilodeau PA, Coleman TA, Porubsky ES,. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009; 119: 1312-1317.
8. Ackerstaff AH, Hilgers FJ, Aaronson NK, Balm AJ,. Communication, functional disorders and lifestyle changes after total laryngectomy. Clin Otolaryngol Allied Sci 1994; 19: 295-300.
9. Hartl DM, Ferlito A, Brasnu DF, et al. Evidence-based review of treatment options for patients with glottic cancer. Head Neck 2011; 33: 1638-1648.
10. Genden EM, Ferlito A, Rinaldo A, et al. Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck 2008; 30: 103-110.
11. Dubben HH, Thames HD, Beck-Bornholdt HP,. Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol 1998; 47: 167-174.
12. Doweck I, Denys D, Robbins KT,. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy. Laryngoscope 2002; 112: 1742-1749.
13. Johnson CR, Khandelwal SR, Schmidt-Ullrich RK, Ravalese J, 3rd, Wazer DE,. The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int J Radiat Oncol Biol Phys 1995; 32: 635-641.
14. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti, A 3rd,. AJCC Cancer Staging Manual. New York, NY: Springer; 2002.
15. Dello SA, van Dam RM, Slangen JJ, et al. Liver volumetry plug and play: do it yourself with ImageJ. World J Surg 2007; 31: 2215-2221.
16. Stenson KM, Maccracken E, Kunnavakkam R, et al. Chemoradiation for patients with large-volume laryngeal cancers. Head Neck 2012; 34: 1162-1167.
17. Mukherji SK, O'Brien SM, Gerstle RJ, Weissler M, Shockley W, Castillo M,. Tumor volume: an independent predictor of outcome for laryngeal cancer. J Comput Assist Tomogr 1999; 23: 50-54.
18. Hoebers FJ, Pameijer FA, de Bois J, et al. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma. Head Neck 2008; 30: 1216-1223.
19. Strongin A, Yovino S, Taylor R, et al. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys 2012; 82: 1823-1830.
20. Studer G, Lutolf UM, El-Bassiouni M, Rousson V, Glanzmann C,. Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT. Acta Oncol 2007; 46: 386-394.